Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection Fendt, Liane
2010
128 2 p. 327-336
artikel
2 Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms Kravchenko, Julia
2011
128 2 p. 483-493
artikel
3 Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up Lemieux, Julie
2011
128 2 p. 563-566
artikel
4 Breast cancer screening and ethnicity in the United States: implications for health disparities research Miranda, Patricia Y.
2011
128 2 p. 535-542
artikel
5 Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival Moran, Meena S.
2011
128 2 p. 543-551
artikel
6 CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo Koch, Manuel
2010
128 2 p. 337-346
artikel
7 Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis Zhang, Chun
2011
128 2 p. 467-472
artikel
8 Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer Wu, Xinyu
2010
128 2 p. 391-400
artikel
9 Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial Li, Xiao-Mei
2011
128 2 p. 411-419
artikel
10 Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence Fu, Huazhou
2011
128 2 p. 595-598
artikel
11 Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy Lalisang, R. I.
2011
128 2 p. 437-445
artikel
12 Erratum to: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy Farante, Gabriel
2010
128 2 p. 379
artikel
13 Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer Razis, E.
2011
128 2 p. 447-456
artikel
14 Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population Zhou, Ping
2011
128 2 p. 527-534
artikel
15 Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry Graña, B.
2011
128 2 p. 573-579
artikel
16 G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer Ignatov, Atanas
2011
128 2 p. 457-466
artikel
17 Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue Lin, Suling J.
2011
128 2 p. 505-516
artikel
18 Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands Ruiterkamp, J.
2011
128 2 p. 495-503
artikel
19 Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs) Oberguggenberger, Anne
2011
128 2 p. 553-561
artikel
20 Limited evidence supported the association of HRAS1 polymorphism with breast cancer risk Zhang, Xiujun
2011
128 2 p. 585-587
artikel
21 Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients Vandorpe, T.
2011
128 2 p. 429-435
artikel
22 No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update He, Taiping
2011
128 2 p. 589-591
artikel
23 Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts Nukatsuka, Mamoru
2010
128 2 p. 381-390
artikel
24 Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control Albert, Jeffrey M.
2011
128 2 p. 421-427
artikel
25 Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73 Wong, Su Wei
2010
128 2 p. 301-313
artikel
26 Reproductive factors associated with mammographic density: a Korean co-twin control study Sung, Joohon
2011
128 2 p. 567-572
artikel
27 RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype Habashy, Hany Onsy
2010
128 2 p. 315-326
artikel
28 Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study Velentzis, Louiza S.
2011
128 2 p. 473-482
artikel
29 Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands—associations with stage at diagnosis and survival Aarts, M. J.
2011
128 2 p. 517-525
artikel
30 The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer Narod, Steven A.
2011
128 2 p. 581-583
artikel
31 The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy Farante, Gabriel
2010
128 2 p. 369-378
artikel
32 Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial O’Malley, F. P.
2011
128 2 p. 401-409
artikel
33 Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth Tolhurst, Robert S.
2010
128 2 p. 357-368
artikel
34 Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer Junttila, Teemu T.
2010
128 2 p. 347-356
artikel
35 Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk Ding, Zhishan
2011
128 2 p. 593-594
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland